Introduction: Maternal risk factors may interfere with mechanisms regulating fetal growth. The aim of the present study was to determine which sociodemographic and reproductive risk factors may be related to fetal growth restriction (FGR), with a special focus on determinants possible for preventive intervention. Materials and Methods: The study period is from May 2007 until December 2009. Data about lifestyle habits were collected by use of a detailed questionnaire in 65 women who attended Riga Maternity Hospital with the confirmed diagnosis of intrauterine FGR of a singleton fetus, and in 65 matched controls with normal pregnancies. Results: Being unmarried (p = 0.04), having pregnancy-related blood pressure rise (p = 0.02), current (p = 0.01) and pre-pregnancy smoking (p = 0.01) and history of more than 3 pregnancy failures (p = 0.04) were more frequent in women with FGR than controls. Surprisingly, the finding of genital infection (STI) during pregnancy (p = 0.006) was also strongly associated with FGR. Conclusions: Obviously, several maternal risk factors play an important role in FGR. Besides refraining from smoking, screening and treating for STI may not only prevent preterm birth, but also FGR. Identifying such anticipating factors would likely have the potential impact if detected before conception, or as early as possible in gestation.

Keywords:
Intrauterine growth restriction, Bacterial vaginosis, Preterm birth, Pre-eclampsia
This content is only available via PDF.
© 2010 S. Karger AG, Basel
2010
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.